Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

NCT07093710 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T Cell Lymphoma

Interventions

DRUG: Golidocitinib
DRUG: Mitoxantrone Hydrochloride Liposome
DRUG: Chidamide

Sponsor

Sun Yat-sen University